ADVANCED STREAM
The COSA CPG Advanced Course 2026 is a must-attend event for experienced oncology pharmacists seeking practical insight into the most complex and rapidly evolving areas of cancer care.
The program aims to include a headline debate: AI in Oncology – Friend, Foe or Future Colleague? Explore whether AI can enhance decision-making and reduce error, or whether safety, accountability and de-skilling risks demand caution.
Across focused didactic sessions, experts will deliver updates in neuro-oncology (gliomas and primary CNS lymphoma) and tackling supportive care in these patients, MDS, and precision NSCLC — from molecular testing and targetable mutations to sequencing, toxicities, CNS activity, and real-world access challenges. Dedicated sessions will tackle safe implementation of bispecifics, and the growing field of cardio-oncology, including risk stratification, surveillance, and prevention strategies.
Interactive workshops will bring learning to life through real-world cases in supportive care, precision NSCLC, primary CNS lymphoma (including HD-methotrexate toxicity and renal impairment), and cardio-oncology.
Designed to be practical, contemporary and clinically relevant, the COSA CPG Advanced Course 2026 will equip participants to confidently manage complexity and deliver safer, smarter oncology care.
**Above topics are proposed abd subject to speaker availability. Whilst we will endevour to present these topics, come may change.
The below program is subject to change.
Feedback from 2024 Advanced Stream participants
“Excellent, informative, diverse range of topics with engaging speakers”
“I thought the weekend was excellent, educational, social and entertaining. The programming was well thought out, having the debate and the interactive MDT sessions later in the program were so good and kept me engaged until the very end of the day.”